Moderna and IBM to Explore Quantum Computing and Generative AI for mRNA Science

We are witnessing a revolution in the world of computing, driven by extraordinary advances in AI and quantum computing,” said Dr. Darío Gil, Senior Vice President, and Director of IBM Research. Moderna will participate in the IBM Quantum Accelerator program and the IBM Quantum Network. Under the agreement, IBM will provide access to quantum computing systems, as well as expertise to assist Moderna in exploring cutting-edge life sciences use-cases powered by quantum technologies. Under this initiative, Moderna and IBM will combine state-of-the-art formulation discovery with generative AI to design mRNA medicines with optimal safety and performance. IBM’s breakthrough innovations in AI, quantum computing, industry-specific cloud solutions and consulting deliver open and flexible options to our clients.